Shield Pharmaceuticals Corp Sustainability Profile
Shield Pharmaceuticals Corp., headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2005, the company has achieved significant milestones, including the launch of several core products that address critical medical needs. With a focus on therapeutic areas such as oncology and infectious diseases, Shield Pharmaceuticals distinguishes itself through its commitment to research and development, ensuring that its offerings are both effective and safe. The company has established a strong market position, recognised for its high-quality formulations and patient-centric approach. As it continues to expand its operational reach, Shield Pharmaceuticals remains dedicated to improving health outcomes globally.
DitchCarbon Score
How does Shield Pharmaceuticals Corp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shield Pharmaceuticals Corp's score of 18 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shield Pharmaceuticals Corp's reported carbon emissions
Shield Pharmaceuticals Corp, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Shield Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Shield Pharmaceuticals aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
How Carbon Intensive is Shield Pharmaceuticals Corp's Industry?
How Carbon Intensive is Shield Pharmaceuticals Corp's Location?
Shield Pharmaceuticals Corp's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shield Pharmaceuticals Corp has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
